ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

Genomatica acquires assets of REG Life Sciences

by Michael McCoy
June 15, 2019 | APPEARED IN VOLUME 97, ISSUE 24

 

The biobased chemical developer Genomatica has acquired the assets of REG Life Sciences, a division of Renewable Energy Group, for an undisclosed sum. REG LS is largely the former LS9, which Renewable Energy Group acquired in 2014 for $40 million. Genomatica says it plans to use the acquired assets, which include over 550 patents and patent applications, to develop sustainable chemicals for cleaning and flavor and fragrance applications. Genomatica’s current focus is on fermentation-derived C4 and C6 chemicals. The acquisition brings technology for longer-chain chemicals.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment